Half-year report · HY
4465.TEDINET S100XFH2
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.1bn | 2025-06-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2025-06-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥879m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2025-06-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2025-06-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥906m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥912m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥912m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | ¥608m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥23.8bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥22.6bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥23.3bn | at 2024-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.6bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2024-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.3bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.9bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥310m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥76m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥420m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥358m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥573m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥946m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥425m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥154.31 | 2025-06-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥305.84 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.03 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.7% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥11.5bn |
| Chemical Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥11.5bn |
| Chemical Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥996m |
| Healthcare Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥673m |
| Healthcare Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥673m |
| Healthcare Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥148m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥12.1bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥12.1bn |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥1.1bn |
| Chemical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| Chemical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥11.0bn |
| Chemical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥731m |
| Healthcare Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥671m |
| Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥671m |
| Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥148m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥11.7bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥879m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 476
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 151031000 | JPY |
| Other ncl | InterimInstant | 152120000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 2884788000 | JPY |
| Noncurrent liabilities | InterimInstant | 2618689000 | JPY |
| Liabilities | Prior1YearInstant | 7827927000 | JPY |
| Liabilities | InterimInstant | 8171068000 | JPY |
| Capital stock | Prior1YearInstant | 585199000 | JPY |
| Capital stock | InterimInstant | 585199000 | JPY |
| Capital surplus | Prior1YearInstant | 614278000 | JPY |
| Capital surplus | InterimInstant | 635143000 | JPY |
| Retained earnings | Prior1YearInstant | 13201747000 | JPY |
| Retained earnings | InterimInstant | 13807047000 | JPY |
| Treasury stock | Prior1YearInstant | -51249000 | JPY |
| Treasury stock | InterimInstant | -18257000 | JPY |
| Shareholders equity | Prior1YearInstant | 14349977000 | JPY |
| Shareholders equity | InterimInstant | 15009133000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 156949000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 374230000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 249806000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 264670000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 406756000 | JPY |
| Valuation and translation adjustments | InterimInstant | 638900000 | JPY |
| Net assets | Prior1YearInstant | 14756733000 | JPY |
| Net assets | InterimInstant | 15648034000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 22584661000 | JPY |
| Liabilities and net assets | InterimInstant | 23819103000 | JPY |
| Net sales | Prior1InterimDuration | 11691076000 | JPY |
| Net sales | InterimDuration | 12139093000 | JPY |
| Cost of sales | Prior1InterimDuration | 7403945000 | JPY |
| Cost of sales | InterimDuration | 7604205000 | JPY |
| Gross profit | Prior1InterimDuration | 4287131000 | JPY |
| Gross profit | InterimDuration | 4534887000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 3408476000 | JPY |
| Selling general and administrative expenses | InterimDuration | 3390604000 | JPY |
| Operating income | Prior1InterimDuration | 878654000 | JPY |
| Operating income | InterimDuration | 1144283000 | JPY |
| Interest income noi | Prior1InterimDuration | 4092000 | JPY |
| Interest income noi | InterimDuration | 17042000 | JPY |
| Dividends income noi | Prior1InterimDuration | 8141000 | JPY |
| Dividends income noi | InterimDuration | 8238000 | JPY |
| Rent income noi | Prior1InterimDuration | 22145000 | JPY |
| Rent income noi | InterimDuration | 22121000 | JPY |
| Foreign exchange gains noi | Prior1InterimDuration | 3172000 | JPY |
| Foreign exchange gains noi | InterimDuration | 18499000 | JPY |
| Other noi | Prior1InterimDuration | 9965000 | JPY |
| Other noi | InterimDuration | 8949000 | JPY |
| Non operating income | Prior1InterimDuration | 47517000 | JPY |
| Non operating income | InterimDuration | 74850000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 3496000 | JPY |
| Interest expenses noe | InterimDuration | 2857000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |